Insights

Most CDMO evaluations are designed to answer one question: can this partner manufacture the product?...

By the time an iPSC-derived product reaches release testing, most of what determines its quality was...

Rethinking CAR-T Manufacturing: A Single-Step Path to Lower COGS and Higher Yield Autologous CAR-T t...

From activation through gene modification and expansion, small development decisions often determine...

Cell therapy involves the transfer of living cells into a patient to treat, cure, or prevent disease...

When mesenchymal stem cells (MSCs) behave, they are remarkably manufacturable. When they do not, the...

MSC manufacturing appears straightforward on paper: initiate, expand, harvest, formulate, cryopreser...

Navigating the Cell Therapy Manufacturing Landscape The journey from scientific discovery to clinica...

The impact of establishing clear objectives, dosing strategies, quality attributes, and critical pro...

Process changes are costly. The earlier you evaluate and optimize your cell therapy manufacturing ap...